China Pharma Holdings (CPHI) Current Assets (2010 - 2026)

China Pharma Holdings' Current Assets history runs 17 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• Quarterly Current Assets fell 29.72% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 29.72% YoY) and the FY2025 annual result came in at $2.3 million, down 28.25% from the prior year.
• Current Assets was $2.0 million for Q1 2026 at China Pharma Holdings, down from $2.3 million in the prior quarter.
• Across five years, Current Assets topped out at $8.2 million in Q1 2022 and bottomed at $2.0 million in Q1 2026.
• A 5-year average of $4.6 million and a median of $5.1 million in 2024 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets jumped 67.22% — and 2024, when it tumbled 45.47%.
• China Pharma Holdings' Current Assets stood at $6.0 million in 2022, then rose by 0.54% to $6.0 million in 2023, then slumped by 45.47% to $3.3 million in 2024, then slipped by 28.25% to $2.3 million in 2025, then declined by 14.61% to $2.0 million in 2026.
• Business Quant data shows CPHI's Current Assets at $2.0 million in Q1 2026, $2.3 million in Q4 2025, and $2.3 million in Q3 2025.